SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations.
Hederman AP, Natarajan H, Heyndrickx L, Ariën KK, Wiener JA, Wright PF, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Rottenstreich A, Zarbiv G, Wolf D, Goetghebuer T, Marchant A, Ackerman ME.
Hederman AP, et al. Among authors: blankson jn.
Nat Commun. 2023 Aug 24;14(1):5171. doi: 10.1038/s41467-023-40960-0.
Nat Commun. 2023.
PMID: 37620337
Free PMC article.